Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Oryzon Genomics S.A.
Sponsor

Oryzon Genomics S.A.

Spain Avinguda De Sant Ferran 74, Poligono Industrial Cornella De Llobregat, 08940 Cornellà de Llobregat, Spain

About the sponsor

Oryzon Genomics S.A. is involved in clinical research on schizophrenia, with a focus on negative symptoms and cognitive impairment in adult patients.

  • Negative symptom burden
  • Cognitive dysfunction
  • Adult psychiatric populations

The sponsor’s portfolio includes studies centered on neuropsychiatric symptom domains that affect daily functioning and clinical outcomes.

About Specializations

Oryzon Genomics S.A. runs clinical trials in conditions such as Schizophrenia, Essential thrombocythaemia, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Schizophrenia

Recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:Vafidemstat
  • Sponsor:Oryzon Genomics S.A.

Essential thrombocythaemia

Recruiting
InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:IADADEMSTAT
  • Sponsor:Oryzon Genomics S.A.

Study of the Safety, Tolerability and Efficacy of Oral Vafidemstat in Adults with Phelan‑McDermid Syndrome (HOPE‑2)

Not yet recruiting
InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Vafidemstat
  • Sponsor:Oryzon Genomics S.A.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.